Model for End Stage Liver Disease and hepatocellular carcinoma: a moving target (Q37639624)

21 August 2017

1 reference

title

Model for End Stage Liver Disease and hepatocellular carcinoma: a moving target (English)

1 reference

21 August 2017

hepatocellular carcinoma

1 reference

Kenneth Washburn

1

1 reference

21 August 2017

1 January 2010

1 reference

21 August 2017

Transplantation Reviews

1 reference

21 August 2017

24

1 reference

21 August 2017

1

1 reference

21 August 2017

11-17

1 reference

Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients

21 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.10.002

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.10.002

The new liver allocation system: moving toward evidence-based transplantation policy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.10.002

Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.10.002

Response to preoperative chemoembolization correlates with outcome after liver transplantation in patients with hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.10.002

Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.10.002

Drop-out rates of patients with hepatocellular cancer listed for liver transplantation: outcome with chemoembolization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.10.002

A follow-up analysis of the pattern and predictors of dropout from the waiting list for liver transplantation in patients with hepatocellular carcinoma: implications for the current organ allocation policy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.10.002

Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.10.002

Liver and intestine transplantation in the United States, 1997-2006

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.10.002

Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.10.002

Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.10.002

Expanded criteria for liver transplantation in patients with hepatocellular carcinoma: a report from the International Registry of Hepatic Tumors in Liver Transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.10.002

Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.10.002

Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.10.002

Liver transplantation outcomes for early-stage hepatocellular carcinoma: results of a multicenter study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.10.002

Liver transplantation for hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.10.002

Resection and liver transplantation for hepatocellular carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.10.002

A novel model measuring the harm of transplanting hepatocellular carcinoma exceeding Milan criteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.10.002

A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.10.002

Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.10.002

A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.10.002

Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.10.002

10.1016/J.TRRE.2009.10.002

7 January 2021

Identifiers

DOI

1 reference

release_azosbb4fqjeqfgd3hikmjvxoqu

21 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/azosbb4fqjeqfgd3hikmjvxoqu

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

19942101

1 reference

PubMed ID

19942101